60th ASH Annual Meeting & Exposition, December 1-4 2018, San Diego, CA
Amir T. Fathi
Massachusetts General Hospital, Boston, US
Interview Topic (English): Alisertib in combination with induction chemotherapy in high-risk patients with AML
For more information and expert opinions in Acute Myeloid Leukemia (AML), please visit: www.amlglobalportal.com
Comments